Schoonhoven M

Publications (1)8.09 Total impact

• Article: Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial

  Gerstein HC, Yusuf S, Holman RR, Bosch J, Anand S, Avezum A, Budaj A, Chiasson JL, Conget I, Dagenais G, [......], Bookelmann Y, Schoonhoven M, Cetin Z, Clare S, Sackett DL, Altman D, Bennett P, Clark CM, Hamman R, Ryden L
  Diabetes Care 05/2008; 31(5):1007-14. · 8.09 Impact Factor